MedTech Dive May 31, 2024
Surmodics will go private when the transaction closes, which is expected in the second half of the year.
Dive Brief:
- Surmodics, a maker of medical device coatings and diagnostics components, has agreed to sell to a private equity firm for approximately $627 million.
- GTCR will acquire the company for $43 per share, or roughly a 41% premium on Surmodics’ volume-weighted average closing price for the 30 days through Tuesday. Surmodics, which announced the deal on Wednesday, will go private when the transaction closes.
- Needham analysts wrote in a note to investors that the deal fairly values Surmodics and they do not expect a higher offer or antitrust issues. Surmodics forecast the deal to close in the second half of...
Today's Sponsors
Today's Sponsor